Botanix Pharmaceuticals Future Growth
Future criteria checks 6/6
Botanix Pharmaceuticals is forecast to grow earnings and revenue by 120.9% and 120.4% per annum respectively. EPS is expected to grow by 112.7% per annum. Return on equity is forecast to be 43.9% in 3 years.
Key information
120.9%
Earnings growth rate
112.7%
EPS growth rate
Pharmaceuticals earnings growth | 33.4% |
Revenue growth rate | 120.4% |
Future return on equity | 43.9% |
Analyst coverage | Low |
Last updated | 21 May 2024 |
Recent future growth updates
No updates
Recent updates
Will Botanix Pharmaceuticals (ASX:BOT) Spend Its Cash Wisely?
Mar 21Here's Why We're Watching Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation
Sep 06Botanix Pharmaceuticals (ASX:BOT) Will Have To Spend Its Cash Wisely
Jan 03Can Botanix Pharmaceuticals (ASX:BOT) Afford To Invest In Growth?
Sep 05Here's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation
May 10We're Not Very Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate
Jan 12We Think Botanix Pharmaceuticals (ASX:BOT) Can Afford To Drive Business Growth
Jul 01We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely
Mar 18The Botanix Pharmaceuticals (ASX:BOT) Share Price Has Gained 81% And Shareholders Are Hoping For More
Jan 24We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely
Nov 30Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 89,200 | 48,000 | N/A | 33,100 | 1 |
6/30/2025 | 30,500 | 9,300 | N/A | -1,500 | 1 |
6/30/2024 | 800 | -11,700 | -9,900 | -10,000 | 1 |
12/31/2023 | 0 | -10 | -27 | -10 | N/A |
9/30/2023 | 2 | -10 | -23 | -11 | N/A |
6/30/2023 | 4 | -9 | -19 | -12 | N/A |
3/31/2023 | 5 | -10 | -20 | -12 | N/A |
12/31/2022 | 6 | -11 | -20 | -12 | N/A |
9/30/2022 | 5 | -12 | -17 | -12 | N/A |
6/30/2022 | 3 | -13 | -14 | -11 | N/A |
3/31/2022 | 1 | -12 | -8 | -7 | N/A |
12/31/2021 | 0 | -11 | -2 | -2 | N/A |
9/30/2021 | 3 | -7 | -3 | -3 | N/A |
6/30/2021 | 7 | -3 | -3 | -3 | N/A |
3/31/2021 | 7 | -6 | -6 | -6 | N/A |
12/31/2020 | 7 | -9 | -8 | -8 | N/A |
9/30/2020 | 7 | -13 | -13 | -13 | N/A |
6/30/2020 | 8 | -17 | -17 | -17 | N/A |
3/31/2020 | 8 | -18 | -21 | -21 | N/A |
12/31/2019 | 8 | -20 | -24 | -24 | N/A |
9/30/2019 | 6 | -18 | -19 | -19 | N/A |
6/30/2019 | 5 | -17 | -13 | -13 | N/A |
3/31/2019 | 5 | -15 | -12 | -12 | N/A |
12/31/2018 | 5 | -13 | -10 | -10 | N/A |
9/30/2018 | 3 | -12 | -10 | -10 | N/A |
6/30/2018 | 2 | -11 | -10 | -10 | N/A |
3/31/2018 | 2 | -8 | -8 | -8 | N/A |
12/31/2017 | 2 | -6 | -7 | -7 | N/A |
9/30/2017 | 1 | -5 | N/A | -6 | N/A |
6/30/2017 | N/A | -5 | N/A | -5 | N/A |
12/31/2016 | N/A | -3 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BOT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: BOT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BOT is expected to become profitable in the next 3 years.
Revenue vs Market: BOT's revenue (120.4% per year) is forecast to grow faster than the Australian market (5.5% per year).
High Growth Revenue: BOT's revenue (120.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BOT's Return on Equity is forecast to be very high in 3 years time (43.9%).